Alterola Biotech, Inc.
ABTI
$0.0013
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -47.81% | -46.47% | 240.83% | -275.90% | -8.69% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.24% | -51.64% | 33.58% | -- | -186.91% |
| Change in Net Operating Assets | -437.36% | 13.81% | -241.58% | 378.76% | -80.09% |
| Cash from Operations | -69.28% | -166.67% | 51.19% | -48.23% | -245.62% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -271.43% | -- | -- | -93.37% | -- |
| Cash from Investing | -129.72% | -- | -- | -93.37% | -- |
| Total Debt Issued | 368.55% | -- | 543.33% | -37.40% | 18.20% |
| Total Debt Repaid | -2,861.56% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -12.33% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -327.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 250.48% | 2,497.40% | 69.63% | 52.42% | -53.54% |
| Foreign Exchange rate Adjustments | -167.11% | 94.60% | -559.13% | -176.38% | 213.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,204.74% | 2,468.95% | 102.56% | -182.61% | 40.95% |